These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6380385)

  • 1. C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.
    Taskinen MR; Groop L
    Ann Clin Res; 1984; 16(2):118-27. PubMed ID: 6380385
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 3. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
    Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
    Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 5. C-peptide response to glycaemic stimuli.
    Samal KC; Das S; Parija CR; Tripathy BB
    J Assoc Physicians India; 1987 May; 35(5):362-4. PubMed ID: 3320022
    [No Abstract]   [Full Text] [Related]  

  • 6. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
    Arteaga A; Velasco N; Szegedi AM; Pellegrino MR; López G; Foradori A; Acosta AM
    Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
    [No Abstract]   [Full Text] [Related]  

  • 7. [The artificial endocrine pancreas in clinical medicine and in research].
    Pfeiffer EF; Beischer W; Thum C; Clemens AH
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():279-96. PubMed ID: 796524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucagon test: criterion for insulin therapy in type II diabetes mellitus].
    Peig M; Coves MJ; Casamitjana R; Soriano G; Guillén M; Figuerola D
    Med Clin (Barc); 1985 Nov; 85(14):568-70. PubMed ID: 3908848
    [No Abstract]   [Full Text] [Related]  

  • 9. Allotransplantation of fresh and cryopreserved islets in patients with type I diabetes: two-year experience.
    Socci C; Davalli AM; Maffi P; Falqui L; Secchi A; Bertuzzi F; Vignali A; Magistretti P; Zammarchi O; Scaglia L
    Transplant Proc; 1993 Feb; 25(1 Pt 2):989-91. PubMed ID: 8442294
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin biosynthesis and C-peptide. Practical applications from basic research.
    Sperling MA
    Am J Dis Child; 1980 Dec; 134(12):1119-21. PubMed ID: 7004174
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of therapy-induced insulin antibodies on glycemic control in type 1 diabetes mellitus.
    Keilacker H; Rjasanowski I; Ziegler M
    Z Med Lab Diagn; 1989; 30(1):65-6. PubMed ID: 2655328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma C-peptide assay and the clinical significance].
    Kaku K; Nagasaka Y; Kaneko T
    Nihon Rinsho; 1990 Feb; 48 Suppl():48-50. PubMed ID: 2192142
    [No Abstract]   [Full Text] [Related]  

  • 15. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 16. [On C-peptide and some other parameters in children with insulin dependent diabetes mellitus (author's transl)].
    Koepp P; Kühnau J
    Monatsschr Kinderheilkd; 1982 Apr; 130(4):215-7. PubMed ID: 7048078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
    Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
    Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advantages of pulsatile administration of human insulin on endogenous pancreatic secretion in the normal subject and in type 1 diabetics].
    Paolisso G; Sgambato S; Scheen AJ; Torella R; Lefebvre PJ
    Ann Med Interne (Paris); 1988; 139(2):144-5. PubMed ID: 3293501
    [No Abstract]   [Full Text] [Related]  

  • 20. [C-peptide determination in type 1 diabetes].
    Zuppinger K; Buetti L; Gallino L; Aebi C
    Ther Umsch; 1983 Oct; 40(10):840-4. PubMed ID: 6359556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.